Work

Rosiglitazone Prevents Advanced Glycation End Products-Induced Renal Toxicity Likely through Suppression of Plasminogen Activator Inhibitor-1

Year: 2006

Type: article

Source: Toxicological Sciences

DOI: 10.1093/toxsci/kfm010

Authors: X. Yu, C. Li, X. Li, L. Cai

Institutions: Jilin University, Wenzhou Medical University, University of Louisville

Language: English

Topic: Advanced Glycation End Products research

Subfield: Clinical Biochemistry

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Diabetes Association, University of Louisville, National Natural Science Foundation of China

Award: G8050690520

OpenAlex ID: W1985750839

FWCI: 1.368

Cites: 42

Cited by: 17

Related to: 10